A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2002
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255824A2 Non-human transgenic animals for the study of neurodegenerative syndromes
11/13/2002	EP1255813A1 Multipotent neural stem cells from peripheral tissues and uses thereof
11/13/2002	EP1255764A1 Purine derivatives
11/13/2002	EP1255756A1 Saccharin derivatives as orally active elastase inhibitors
11/13/2002	EP1255755A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/13/2002	EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002	EP1255740A2 Substituted arylpyrazines
11/13/2002	EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002	EP1255735A2 Pyridine derivatives as potentiators of glutamate receptors
11/13/2002	EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002	EP1255732A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
11/13/2002	EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1255556A2 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
11/13/2002	EP1255551A1 Use of paullone derivatives for making medicines
11/13/2002	EP1255547A1 Controlled-release compositions containing opioid agonist and antagonist
11/13/2002	EP1255536A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
11/13/2002	EP1255535A2 Controlled release pharmaceutical composition containing tramadol hydrochloride
11/13/2002	EP1187824B1 Novel (2-substituted-5 - 3-thienyl) -benzyl]- 2- ( 2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments
11/13/2002	EP1112272B1 Muscarinic agonists and antagonists
11/13/2002	EP1102762B1 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
11/13/2002	EP1068199B1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
11/13/2002	EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002	EP1012162B1 Soluble proteins
11/13/2002	EP0950057B1 3-pyridyl enantiomers and their use as analgesics
11/13/2002	EP0912515B1 1,4-di-substituted piperidines as muscarinic antagonists
11/13/2002	EP0843672B1 One pot synthesis of 2-oxazolidinone derivatives
11/13/2002	EP0788795B1 Pharmacologically active 2-mercaptobenzimidazole derivatives
11/13/2002	EP0777477B1 Improved pharmaceutical formulations containing ibuprofen and codeine
11/13/2002	EP0748320B1 Prodrugs of morpholine tachykinin receptor antagonists
11/13/2002	CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions
11/13/2002	CN1379781A Novel oligosaccharides, preparation method and pharmaceutical composition containing same
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/13/2002	CN1379776A Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
11/13/2002	CN1379775A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379767A Isoxazolecarboxamide derivatives
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002	CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/13/2002	CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives
11/13/2002	CN1379686A Composition comprising tramadol material and anticonvulsant drug
11/13/2002	CN1379685A Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
11/13/2002	CN1379681A therapeutic angiogenic factors and methods for their use
11/13/2002	CN1379679A Methods for treating pain
11/13/2002	CN1379678A Method for calming human beings using personal care compositions
11/13/2002	CN1379672A Highly selective norepinephrine reuptake inhibitors and methods of using same
11/13/2002	CN1379671A Treating sleep disorders using desloratadine
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process
11/13/2002	CN1378840A Slow-releasing composition of estrogen medicine and its preparing process
11/13/2002	CN1378838A Process for preparing medicine to prevent and treat recurrence of heroin dependent patient
11/13/2002	CN1378837A Application of danshinolic acid compounds in preparing medicines
11/12/2002	US6479553 Use of certain affinity NMDA antagonists as antidepressants
11/12/2002	US6479551 Treatment of migraine headache
11/12/2002	US6479549 Alzheimer's disease; antiischemic agents
11/12/2002	US6479545 Formulation for menopausal women
11/12/2002	US6479544 Therapeutic combinations of fatty acids
11/12/2002	US6479540 Compositions of tocol-soluble therapeutics
11/12/2002	US6479536 Benzofuran derivatives, process for the preparation of the same and uses thereof
11/12/2002	US6479534 Indoline derivatives and method of treating obesity
11/12/2002	US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002	US6479530 Substituted 4(5)-(1-indanyl,-indanylmethyl, indanylmethylen), 4(5)-(1-(1,2,3,4-tetrahydronaphthyl, -naphthylmethyl and naphthylmethylen)imidazoles; hypotensive, ischemic and anxiolytic agents; nervous and muscular system disorders
11/12/2002	US6479528 Methods for inhibiting or reversing tau filament formation polymerization
11/12/2002	US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002	US6479518 Zwitterionic tachykinin receptor antagonists
11/12/2002	US6479510 N-((2s,3r)-2-methyl-1-azabicyclo(2.2.2)oct-3-yl)-4-(4-hydroxyp henoxy)- benzamide for example; treating diseases of the alpha-7-nicotinic acetylcholine receptor i.e. schizophrenia, or psychosis
11/12/2002	US6479509 Method of promoting smoking cessation
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479506 Triazolo-pyridine derivatives as ligands for GABA receptors
11/12/2002	US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002	US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002	US6479497 Compounds having a selective effect at a subgroup of 5-hydroxytryptamine receptors, designated the h5-ht1b receptor
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479491 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
11/12/2002	US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002	US6479488 Good in vitro affinity for the strychnine insensitive glycine binding site associated with the nmda receptor complex but also good in vivo activity when administered systemically
11/12/2002	US6479487 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
11/12/2002	US6479484 Substituted 2-aminoacetamides and the discovery that these compounds act as blockers of sodium channels; pain relievers, treatment of arrythmia, local anesthetics
11/12/2002	US6479483 3,4,6-substituted pyridine derivatives useful for treating depression and pain, resulting from inflammatory conditions, such as migraine, rheumatoid arthritis, asthma and inflamatory bowel disease; nk1 receptor antagonist
11/12/2002	US6479481 Administering an effective dose of a cns tumor-inhibiting methylol transfer agent such as: taurolidine, taurultam or a mixture thereof.
11/12/2002	US6479479 Azetidine derivatives, their preparation and pharmaceutical compositions containing them
11/12/2002	US6479477 Substituted porphyrins
11/12/2002	US6479474 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
11/12/2002	US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/12/2002	US6479080 Plant extract
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/12/2002	CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/12/2002	CA2244253C Method for preventing and treating peripheral neuropathy by administering selegiline
11/12/2002	CA2169718C The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
11/12/2002	CA2144294C (pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments

1 ... 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 ... 1833